Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease

Mucosal Immunology

Volumn 6, Issue 3, 2013, Pages 569-579

  Starkey, M R ^a   Essilfie, A T ^a   Horvat, J C ^a   Kim, R Y ^a   Nguyen, D H ^a   Beagley, K W ^b   Mattes, J ^a   Foster, P S ^a   Hansbro, P M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 13 RECEPTOR ALPHA2; STAT6 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; MOUSE; MUCOUS CELL; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFECTION; WILD TYPE;

EID: 84876372773     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.99     Document Type: Article

References (50)

1. Kuo, C.C., Jackson, L.A., Campbell, L.A. & Grayston, J.T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8, 451-461 (1995).
2. Grayston, J.T. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 43, 317-323 (1992).
3. Blasi, F. Atypical pathogens and respiratory tract infections. Eur. Respir. J. 24, 171-181 (2004).
4. Harrison, H.R, Taussig, L.M. & Fulginiti, V.A. Chlamydia trachomatis and chronic respiratory disease in childhood. Pediatr. Infect. Dis. 1, 29-33 (1982).
5. Beagley, K.W., Huston, W.M., Hansbro, P.M. & Timms, P. Chlamydial infection of immune cells: altered function and implications for disease. Crit. Rev. Immunol. 29, 275-305 (2009).
6. Hansbro, P.M., Beagley, K.W., Horvat, J.C. & Gibson, P.G. Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol. Ther. 101, 193-210 (2004).
7. Jupelli, M. et al. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. J. Immunol. 180, 4148-4155 (2008).
8. Jupelli, M. et al. The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge. J. Interferon Cytokine Res. 30, 407-415 (2010).
9. Zaitsu, M. Does Chlamydia pneumoniae infection trigger todevelopment of asthma in wheezy infants?. J. Asthma 46, 967-968 (2009).
10. Webley, W.C. et al. Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae inpaediatric respiratory infections. Eur. Respir. J. 33, 360-367 (2009).
11. Webley, W.C. et al. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. Am. J. Respir. Crit. Care Med. 171, 1083-1088 (2005).
12. Hansbro, P.M., Starkey, M.R., Kim, R.Y., Foster, P.S. & Horvat, J.C. Programming of the lung by early life infection. J. Dev. Orig. Health Dis. 3, 153-158 (2012).
13. Hansbro, P.M., Kaiko, G.E. & Foster, P.S. Cytokine/anti-cytokine therapy-novel treatments for asthma?. Br. J. Pharmacol. 163, 81-95 (2011).
14. Hansbro, N.G., Horvat, J.C., Wark, P.A. & Hansbro, P.M. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol. Ther. 117, 313-353 (2008).
15. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258-2261 (1998).
16. Yang, M. et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 25, 522-530 (2001).
17. Kuperman, D.A. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885-889 (2002).
18. Tabata, Y. & Khurana Hershey, G.K. IL-13 receptor isoforms: breaking through the complexity. Curr. Allergy. Asthma Rep. 7, 338-345 (2007).
19. Grunig, G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263 (1998).
20. Taube, C. et al. The role of IL-13 in established allergic airway disease. J. Immunol. 169, 6482-6489 (2002).
21. Wilson, M.S. et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J. Clin. Invest. 117, 2941-2951 (2007).
22. Zheng, T. et al. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. J. Immunol. 180, 522-529 (2008).
23. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35 (2003).
24. Martinez, F.O., Helming, L. & Gordon, S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483 (2009).
25. Murray, P.J. & Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011).
26. Horvat, J.C. et al. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am. J. Respir. Crit. Care Med. 176, 556-564 (2007).
27. Horvat, J.C. et al. Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J. Allergy Clin. Immunol. 125, 617-625. 625 e611-625 e616 (2010).
28. Jupelli, M. et al. Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life. Lab. Invest. 91, 1530-1539 (2011).
29. Asquith, K.L. et al. Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog. 7, e1001339 (2011).
30. Kaiko, G.E. et al. Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J. Immunol. 180, 2225-2232 (2008).
31. El Kasmi, K.C. et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9, 1399-1406 (2008).
32. Donaldson, D.D. et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J. Immunol. 161, 2317-2324 (1998).
33. O'Toole, M., Legault, H., Ramsey, R., Wynn, T.A. & Kasaian, M.T. A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressedinplasma of healthy orasthmatic subjects. Clin. Exp. Allergy 38, 594-601 (2008).
34. Chen, W. et al. IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice. J. Immunol. 183, 7870-7876 (2009).
35. MacMicking, J., Xie, Q.W. & Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350 (1997).
36. Igietseme, J.U. et al. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun. 66, 1282-1286 (1998).
37. Schneider, D. et al. Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. J. Immunol. 188, 2894-2904 (2012).
38. Lukacs, N.W. et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J. Immunol. 167, 1060-1065 (2001).
39. You, D. et al. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir. Res. 7, 107 (2006).
40. Horvat, J.C. et al. Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J. Immunol. 184, 4159-4169 (2010).
41. Preston, J.A. et al. Inhibition of allergic airways disease by immunomo-dulatory therapy with whole killed Streptococcus pneumoniae. Vaccine25, 8154-8162 (2007).
42. Essilfie, A.T. et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67, 588-599 (2012).
43. Beckett, E.L. et al. TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tractinfectionin early life. PLoS One 7, e39460 (2012).
44. Chen, W. et al. Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo. J. Allergy Clin. Immunol. 122, 625-632 (2008).
45. Berry, L.J. et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect. Immun. 72, 1019-1028 (2004).
46. Essilfie, A.T. et al. Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 7, e1002244 (2011).
47. Preston, J.A. et al. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur. Respir. J. 37, 53-64 (2011).
48. Thorburn, A.N. et al. Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells. J. Immunol. 188, 4611-4620 (2012).
49. Thorburn, A.N. et al. Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease. Thorax 65, 1053-1060 (2010).
50. Starkey, M.R. et al. Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice. PLoS One 7, e42588 (2012).